Debra Yu
2020
In 2020, Debra Yu earned a total compensation of $3.4M as President & Chief Strategy Officer at LianBio.
Compensation breakdown
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Option Awards | $2,257,759 |
| Salary | $500,000 |
| Other | $125,000 |
| Total | $3,382,759 |
Yu received $2.3M in option awards, accounting for 67% of the total pay in 2020.
Yu also received $500K in non-equity incentive plan, $500K in salary and $125K in other compensation.
Rankings
In 2020, Debra Yu's compensation ranked 3,438th out of 13,090 executives tracked by ExecPay. In other words, Yu earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,438 out of 13,090 | 74th |
Division Manufacturing | 1,339 out of 5,621 | 76th |
Major group Chemicals And Allied Products | 505 out of 2,254 | 78th |
Industry group Drugs | 438 out of 1,954 | 78th |
Industry Pharmaceutical Preparations | 328 out of 1,459 | 78th |
Source: SEC filing on April 27, 2022.
Yu's colleagues
We found one more compensation record of an executive who worked with Debra Yu at LianBio in 2020.
2020
Bing Li
LianBio